A systematic review and meta-analysis found that adding immune checkpoint inhibitors to chemotherapy significantly improves progression-free survival, but not overall ...
A systematic review found no statistically significant correlation between preclinical rodent xenograft efficacy endpoints and phase II trial outcomes in ...
A retrospective single-center study found that early brain radiotherapy combined with third-generation EGFR-TKIs was associated with significantly longer survival outcomes ...
A decision-tree simulation shows that pathologist-initiated reflex testing for non-small cell lung cancer improves survival while lowering annual healthcare expenditures ...
A retrospective cohort study demonstrates that baseline splenic volume of 315 cubic centimeters or greater independently predicts significantly shorter progression-free ...
A single-arm exploratory study reports an 88.2 percent 12-week objective response rate and preliminary two-year survival estimates for nimotuzumab added ...
A study of Brazilian triple-negative breast cancer patients found improved progression-free survival in carriers of BRCA1 and HRR variants alongside ...
Integrating three-dimensional spatial topology features from baseline PET/CT with volumetric burden metrics significantly improves two-year progression-free survival risk stratification in ...
A retrospective cohort study of 230 patients with intermediate-stage hepatocellular carcinoma found that adding complete ablation to transarterial chemoembolization and ...
A large-scale retrospective analysis of 1,751 surgical meningioma cases reveals that digital quantification of phosphorylated retinoblastoma protein independently predicts tumor ...
Elevated TBRG4 expression correlates with adverse clinicopathological features in prostate cancer and promotes tumor growth and cell invasion in experimental ...
Preclinical and clinical investigations reveal that the transcription factor TFAP2A enhances radiotherapy resistance in non-small cell lung cancer by directly ...
A retrospective cohort study found that androgen receptor expression and the androgen-to-estrogen receptor ratio did not independently predict progression-free survival ...
A retrospective cohort study found that initial hepatic arterial infusion chemotherapy was associated with longer overall survival and higher response ...
A retrospective study of 160 patients evaluated an integrated metabolic vulnerability score to stratify progression-free survival in non-metastatic nasopharyngeal carcinoma.
15-year follow-up of the SWOG S0016 trial estimates a 42% cured fraction in advanced follicular lymphoma, challenging the view of ...
A real-world study of 561 patients aged 65–75 finds that autologous stem cell transplantation and quadruplet therapy improve progression-free survival, ...
A retrospective study of 170 patients shows that the modified five-factor frailty index predicts postoperative complications and survival outcomes after ...
A systematic review and meta-analysis of eight randomized controlled trials demonstrates that adding pertuzumab to standard therapies significantly improves progression-free ...
A prospective cohort study in India demonstrates that first-line lenvatinib provides meaningful survival outcomes and manageable safety in advanced hepatocellular ...
